Maharashtra to set up single-window system to grant clearances, address grievances for pharma firms

Food and Drug Administration (FDA) Minister Jaykumar Rawal recently held meetings with representatives of the Indian Drug Manufacturing Association to understand why the pharma companies, for whom Maharashtra was earlier a preferred destination, shifted to Himachal Pradesh in recent years.

MUMBAI: The Maharashtra government is planning to attract pharmaceutical companies to set up base in the state and has decided to set up a single-window system to grant them clearances and their grievances.

Food and Drug Administration (FDA) Minister Jaykumar Rawal recently held meetings with representatives of the Indian Drug Manufacturing Association to understand why the pharma companies, for whom Maharashtra was earlier a preferred destination, shifted to Himachal Pradesh in recent years.

Earlier, around 3,000 pharma companies had their manufacturing units in Maharashtra. But gradually, the majority of them shifted to Himachal Pradesh due to various sops offered there, Rawal told reporters here during the weekend.

"I found out during my meetings with the stakeholders that these companies face a big hurdle in getting environmental clearances. The FDA will set up a single-window clearance system to help in this matter," he said.

Rawal said there were plans to make Nagpur and Aurangabad as the 'pharma hubs' in the state.

Read Also: Hikma Pharma signs agreement with Civica Rx to produce 14 sterile injectable medications

In Nagpur, work is already in progress at MIHAN (Multi-modal International Cargo Hub and Airport at Nagpur), he noted.

"The focus will be on the production of Ayurvedic medicines. There are plans to make a pharma hub between Aurangabad and Nashik along the Mumbai-Nagpur Samruddhi Corridor. Plans are also afoot to set up a world-class lab at the pharma hubs," the minister said.

"We want to compete with China in the production of generic medicines," he further said.

The Indian pharma products have a good response in Europe, he said, adding that Bosnia is keen on joint cooperation with Maharashtra in the pharma sector.

Read Also: Protest planned outside court during Purdue Pharma hearing